EVOLOCUMAB

165049 reported adverse events

Drug classes: PCSK9 Inhibitor [EPC]

These side effects are most commonly reported by patients taking EVOLOCUMAB:

# Side effect Count
0 DEVICE DIFFICULT TO USE 33254
1 DRUG DOSE OMISSION BY DEVICE 24856
2 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22690
3 ACCIDENTAL EXPOSURE TO PRODUCT 17173
4 INJECTION SITE PAIN 11254
5 PRODUCT STORAGE ERROR 6709
6 BACK PAIN 5658
7 MYALGIA 5484
8 INJECTION SITE BRUISING 4954
9 DRUG DOSE OMISSION 4929
See all common reactions for EVOLOCUMAB

EVOLOCUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 122 0.6816
1 INCORRECT DISPOSAL OF PRODUCT 1746 0.5371
2 LOW DENSITY LIPOPROTEIN DECREASED 738 0.5208
3 DEVICE DIFFICULT TO USE 33254 0.5019
4 PRODUCT COMMUNICATION ISSUE 2936 0.3325
5 LOW DENSITY LIPOPROTEIN ABNORMAL 202 0.3295
6 INTERCEPTED PRODUCT ADMINISTRATION ERROR 2523 0.3287
7 DRUG DOSE OMISSION BY DEVICE 24856 0.3171
8 TYPE IIA HYPERLIPIDAEMIA 71 0.3034
9 PRODUCT KNOWLEDGE DEFICIT 205 0.2621
See all enriched reactions for EVOLOCUMAB